Companies are testing COVID-19 vaccines right now -- if all goes smoothly, more than one may get to market at “warp speed.”
News & Analysis: AstraZeneca
Moderna was seen as the leader in the COVID-19 vaccine race -- now it’s sharing the limelight.
Emergent BioSolutions has become the go-to manufacturing partner for companies looking to develop vaccines for the coronavirus.
Hint: It's not Moderna.
The results indicate that a prime dose plus a booster notably increases its effect.
The contract manufacturer will be able to supply hundreds of millions of doses of AZD1222 starting in August.
Britain's biggest pharmaceutical has expanded its agreements with two U.S. government agencies and Vanderbilt University.
AstraZeneca's Acquisition of Gilead Would Create a COVID-19 Colossus -- but Don't Bet on Seeing It Happen
This reported deal would be massive. But it's not likely to move forward.
The pharmaceutical giant signed agreements with heavy hitters in the vaccine manufacturing industry.
The White House reportedly plans to route extra federal funds and other assistance to the companies developing those potential SARS-CoV-2 vaccines.